RAB1B · Western blot design guide

RAB1B Western Blot Planning Guide

Plan a RAB1B Western blot around the catalog-observed 22.2 kDa band, image-backed A04589-1 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for RAB1B (RAB1B): expected band 22.2 kDa, antibody A04589-1, and guide-derived SDS-PAGE protocol steps
RAB1B Western blot protocol sheet — expected band 22.2 kDa, antibody A04589-1, controls and PMC citations. Open the full RAB1B WB guide →

RAB1B Western Blot Experimental Design Guide

Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 22.2 kDa
Observed band Not reported — verify product WB image
Gel 12-15%
Positive control ⓘ Ovary
Negative control ⓘ Bone marrow
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 22.2 kDa
ⓘ Localization Cytoplasm / Membrane
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human / Mouse / Rat
Section 1

Real Curated RAB1B Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateDuodenum
Gel %12-15%
Load20-30 µg total protein per lane
TransferSemi-dry, short transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA04589-1 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected RAB1B Western Blot Band Size?

Use the product-observed 22.2 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
22.2 kDaMatches the authoritative product WB observation.
22.2 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected RAB1B appearancePlan around 22.2 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band22.2 kDa; use this as the primary experimental expectation.
Calculated mass22.2 kDa from UniProt Q9H0U4; retain as context.
Gel selection12-15%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A04589-1.
Why is my band missing or off?
SituationLikely causeNext action
22.2 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for RAB1B Western blot

🧪Use Ovary as the first positive-control candidate and Bone marrow as the HPA Not detected negative candidate.
Positive control: Ovary (High)
Negative control: Bone marrow (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for RAB1B

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Ovary Reported tissue cells High Protein (HPA) HPA →
Small intestine Reported tissue cells High Protein (HPA) HPA →
Duodenum Reported tissue cells High Protein (HPA) HPA →
Epididymis Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Bone marrow Reported tissue cells Not detected Protein (HPA) HPA →
Caudate Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced RAB1B Western Blot Tips

Deeper troubleshooting and optimisation questions for RAB1B, answered from its protein features.

Which band should guide the blot?
Use 22.2 kDa, the observation attached to the authoritative A04589-1 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 22.2 kDa expectation.
Which positive control should I start with?
Start with Ovary, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Bone marrow as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for RAB1B Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A04589-1 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

RAB1B Western Blot Reagents

Human/Mouse/Rat-reactive RAB1B Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for RAB1B using A04589-1; observed band 22.2 kDa
Anti-RAB1B Antibody Picoband®
Cat # A04589-1

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.

References

  1. UniProt Q9H0U4
  2. Human Protein Atlas — RAB1B
  3. A04589-1 product record
  4. PMC10979127 — A guide to selecting high-performing antibodies for Rab1A and Rab1B for use in Western Blot, immunoprecipitation and immunofluorescence (F1000Research, 2023)
  5. PMC5391239 — Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer (Aging, 2017)